Patents by Inventor Martin John Charles Turner

Martin John Charles Turner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid encoding modified human tnf.alpha. (tumor necrosis factor alpha) receptor
    Patent number: 5863786
    Abstract: A DNA molecule is provided which encodes a polypeptide which is capable of binding human TNF.alpha. and which has the first three cysteine-rich subdomains, but not the fourth cysteine-rich subdomain, of the extracellular binding domain of a receptor selected from the 55 kD and 75 kD receptors for human TNF.alpha.. The ability of the polypeptide to bind to TNF.alpha. means that it can be used for treating diseases mediated by TNF.alpha. activity, such as rheumatoid arthritis.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: January 26, 1999
    Assignee: The Mathilda and Terence Kennedy Institute of Rheumatology
    Inventors: Marc Feldmann, Patrick William Gray, Martin John Charles Turner, Fionula Mary Brennan